GoodRx Holdings (GDRX) Return on Invested Capital (2020 - 2026)

GoodRx Holdings has disclosed Return on Invested Capital across 7 years of filings, most recently posting 0.0% for Q1 2026.

• Return on Invested Capital for Q1 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital came in at 0.0% for Q1 2026 at GoodRx Holdings, down from 0.0% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q3 2024 to a low of 0.0% in Q2 2022.
• The 5-year median for Return on Invested Capital is 0.0% (2022), against an average of 0.0%.
• Peak annual rise in Return on Invested Capital reached 0 bps in 2022, while the deepest fall reached 0 bps in 2022.
• GoodRx Holdings' Return on Invested Capital stood at 0.0% in 2022, then plunged by 235 bps to 0.0% in 2023, then soared by 1079 bps to 0.0% in 2024, then surged by 50 bps to 0.0% in 2025, then declined by 26 bps to 0.0% in 2026.
• The last three Return on Invested Capital figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.